Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,839,059
-$2,469,621 QoQ
Shares Held
439,099
-37.3% QoQ
Ownership
0.825%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.99270324004382.ToString("F0")%
Shared 0.ToString("F0")%
None 4.0072967599561835.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. KALV ranks #143 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,839,059 | 439,099 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,308,680 | 700,228 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $6,879,941 | 564,856 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,709,002 | 239,629 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,582,521 | 223,789 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,452,188 | 289,515 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,443,912 | 297,402 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,988,515 | 338,584 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,033,784 | 424,434 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $5,542,315 | 452,434 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,021,604 | 209,928 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,823,607 | 202,623 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,507,355 | 191,776 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,636,167 | 833,753 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $448,094 | 30,882 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $583,696 | 59,319 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $993,165 | 67,379 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $834,598 | 63,084 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $298,759 | 17,121 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $235,165 | 9,815 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $765,946 | 29,815 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $233,614 | 12,302 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $63,602 | 5,052 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $74,765 | 6,179 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $151,407 | 19,792 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||